EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Type I interferons induced upon respiratory viral infection impair lung metastatic initiation

Ana Farias iD, Victoria L Bridgeman, Felipe S Rodrigues iD, Franz Puttur iD, Amber Owen iD, Stefanie Ruhland iD, Rute M M Ferreira, Matthias Mack, Ilaria Malanchi iD, Cecilia Johansson iD

Proceedings of the National Academy of Sciences · 21.04.2026 · 123 (16)

DOI: 10.1073/pnas.2412919123 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 17.04.2026. Verfasst von Ana Farias und 9 weiteren Autor:innen. Beteiligte Einrichtung: Respiratory Infections Section, National Heart and Lung Institute, Imperial College London, London W12 0NN, United Kingdom. Hauptthemen laut MEDLINE: Lung Neoplasms, Interferon Type I, Respiratory Syncytial Virus Infections, Respiratory Tract Infections. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Research UK (CRUK), UKRI | Medical Research Council (MRC), Wellcome Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metastatic breast cancer accounts for 7% of cancer-related deaths, with the lungs being a common site of cancer spread. In parallel, lower respiratory tract infections, including those caused by respiratory syncytial virus (RSV), remain a common cause of morbidity and mortality worldwide. Acute viral respiratory infections induce marked changes in the lung. However, how these changes influence metastasis initiation and cancer progression remains unclear. Using breast cancer and other cancer cell types in an experimental lung metastasis model, we show that RSV infection impairs tumor cell seeding and early growth in the lung, resulting in fewer metastatic nodules. We demonstrate that restriction of metastatic spread is due to alterations in the lung environment mediated by RSV-induced type I interferons (IFNs). Consistent with this idea, intranasal administration of recombinant IFN-α is sufficient to recapitulate the anti-metastatic effect of RSV infection. Using single cell RNA sequencing supported by in vivo and ex vivo validation, we show that IFN-α influences interactions between epithelial/endothelial cells and cancer cells. Furthermore, both RSV infection and IFN-α administration trigger marked local and systemic upregulation of Galectin-9, an IFN-inducible protein associated with acute respiratory infection in humans. Treatment of cancer cells with Galectin-9 alone is sufficient to restrict metastatic seeding. Altogether, our results suggest that type I IFNs induced by respiratory virus infection render the lungs less permissive to cancer cell seeding and consequently interfere with the ability of tumor cells to successfully initiate metastatic colonization.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsInterferon Type IRespiratory Syncytial Virus InfectionsRespiratory Tract InfectionsAnimalsFemaleHumansMiceInterferon-alphaCell Line, TumorRespiratory Syncytial VirusesNeoplasm MetastasisLungBreast Neoplasms

Stichwörter der Autor:innen

epithelial cellsimmune cellslung metastasesvirus infection

Substanzen

Interferon Type IInterferon-alpha

Autor:innen und Institutionen

  • Respiratory Infections Section, National Heart and Lung Institute, Imperial College London, London W12 0NN, United Kingdom.
  • Tumor-Host Interaction Laboratory, The Francis Crick Institute, London NW1 1AT, United Kingdom.
  • Inflammation Repair and Development, National Heart and Lung Institute, Imperial College London, London W12 0NN, United Kingdom.
  • Department of Nephrology, University Hospital Regensburg, Regensburg 93053, Germany.

ORCID-Profile: Ana Farias, Felipe S Rodrigues, Franz Puttur, Amber Owen, Stefanie Ruhland, Ilaria Malanchi, Cecilia Johansson

Förderung

  • Cancer Research UK (CRUK)
  • UKRI | Medical Research Council (MRC)
  • Wellcome Trust

Zitieren

APA

Farias, A., Bridgeman, V. L., Rodrigues, F. S., Puttur, F., Owen, A., Ruhland, S., Ferreira, R. M. M., Mack, M., Malanchi, I., & Johansson, C. (2026). Type I interferons induced upon respiratory viral infection impair lung metastatic initiation. Proceedings of the National Academy of Sciences, 123(16). https://doi.org/10.1073/pnas.2412919123

Vancouver

Farias A, Bridgeman VL, Rodrigues FS, Puttur F, Owen A, Ruhland S, et al. Type I interferons induced upon respiratory viral infection impair lung metastatic initiation. Proceedings of the National Academy of Sciences. 2026;123(16). doi:10.1073/pnas.2412919123

BibTeX
@article{Farias2026,
  author = {Farias, Ana and Bridgeman, Victoria L and Rodrigues, Felipe S and Puttur, Franz and Owen, Amber and Ruhland, Stefanie and Ferreira, Rute M M and Mack, Matthias and Malanchi, Ilaria and Johansson, Cecilia},
  title = {Type I interferons induced upon respiratory viral infection impair lung metastatic initiation},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2026},
  volume = {123},
  number = {16},
  doi = {10.1073/pnas.2412919123}
}
Kostenlos starten →